TREA

97695250 - RADIOHYBRID

Follow

Information

  • Trademark
  • 97695250
  • Serial Number
    97695250
  • Filing Date
    November 29, 2022
    2 years ago
  • Registration Date
    February 18, 2025
    13 days ago
  • Transaction Date
    January 28, 2025
    a month ago
  • Status Date
    January 28, 2025
    a month ago
  • Location Date
    January 28, 2025
    a month ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GLUECK, CHRISTOPHER
  • Attorney Docket Number
    1476.002TM
    Attorney Name
    Andrew D. Bochner
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
RADIOHYBRID
Case File Statements
  • GS0051: Medical, pharmaceutical and veterinary preparations for diagnosis, monitoring and treatment of cancer; sanitary preparations for medical use; diagnostic preparations for medical purposes; medical preparations in the nature of biometallic compounds for consumption or injection for use in medical imaging; contrast agents for use in medical imaging; amino acids for medical purposes; radioactive substances for medical purposes; reagents for medical use; Positron Emission Tomography (PET) tracer chemicals for medical use; Positron Emission Tomography (PET) tracer chemicals prepared for ingestion or injection into humans and animals for medical purposes; diagnostic chemicals for medical purposes; Therapeutic pharmaceutical for the treatment of cancer; reagents for medical purposes; diagnostic scanning agents for medical use; pharmaceutical preparations, namely, radiotherapeutic preparations and radio diagnostic preparations; Diagnostic medical preparations for use in molecular imaging; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; diagnostic radiopharmaceutical preparations; radiopharmaceutical products, namely, radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy; Pharmaceutical preparations, namely, alpha- and beta-emitting radionuclides for use in radionuclide therapy; synthetic amino acids for medical purposes, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy; reagents for medical use, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy
  • PM0001: RADIO HYBRID
  • GS0011: Chemicals for use in scientific research, other than for medical or veterinary purposes; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracer chemicals for scientific and laboratory use; radioactive elements for scientific purposes; diagnostic scanning agents for in-vivo use other than medical purposes; chemicals for use in molecular imaging for scientific or research use
  • GS0441: Medical clinic services; Positron Emission Tomography (PET) imaging services; medical imaging services; medical analysis for the diagnosis and treatment of persons; medical consultations
  • GS0421: Scientific and technological services, namely, research and design in the field of industrial analysis; industrial analysis and research services in the field of radiopharmaceuticals; design and development of computer hardware and software; product design and development in the field of Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in the field of disease diagnosis and treatment; scientific and medical research in the field of molecular imaging; development of molecular imaging products; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific research consulting in the field of medical imaging; Medical laboratory services
Case File Event Statements
  • 12/2/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 12/21/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/24/2023 - a year ago
    3 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/24/2023 - a year ago
    4 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/24/2023 - a year ago
    5 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/8/2023 - a year ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/14/2023 - a year ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/14/2023 - a year ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/14/2023 - a year ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/14/2023 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/6/2024 - 10 months ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 5/6/2024 - 10 months ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/6/2024 - 10 months ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/1/2024 - 4 months ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 11/1/2024 - 4 months ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 11/1/2024 - 4 months ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 1/23/2025 - a month ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 1/24/2025 - a month ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/24/2025 - a month ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/24/2025 - a month ago
    20 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/27/2025 - a month ago
    21 - APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Type: CNTA